Finance

Lists
600422:SHA
KPC Pharmaceuticals Inc
CNÂ¥8.40
+0.12%
(+0.0100) 1D
Oct 16, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600422...
Open
CNÂ¥8.44
High
CNÂ¥8.62
Low
CNÂ¥8.33
Mkt. cap
6.31B
Avg. vol.
4.40M
Volume
7.84M
Dividend
2.14%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 30, 2025
52-wk high
CNÂ¥14.46
52-wk low
CNÂ¥7.45
EPS
-CNÂ¥0.28
Shares outstanding
764.20M
No. of employees
5K
Open
CNÂ¥8.44
High
CNÂ¥8.62
Low
CNÂ¥8.33
Mkt. cap
6.31B
Avg. vol.
4.40M
Volume
7.84M
Dividend
2.14%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jul 30, 2025
52-wk high
CNÂ¥14.46
52-wk low
CNÂ¥7.45
EPS
-CNÂ¥0.28
Shares outstanding
764.20M
No. of employees
5K
News stories
From web sources and news partners
About KPC Pharmaceuticals Inc
CEO-
Employees5.07K
Founded1951
Headquarters-
SectorPharmaceutical industry
Websitekpc.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.40B
1.82B
836.16M
806.89M
Cost of goods sold
857.81M
1.18B
647.46M
724.42M
Cost of revenue
857.81M
1.18B
647.46M
724.42M
Research and development expenses
28.91M
29.75M
15.27M
16.04M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
513.66M
590.24M
325.05M
242.67M
Operating expense
520.28M
671.10M
359.94M
322.71M
Total operating expenses
1.38B
1.86B
1.01B
1.05B
Operating income
21.77M
-31.65M
-171.24M
-240.25M
Other non operating income
10.82M
-17.68M
-2.66M
2.61M
EBT including unusual items
79.48M
95.14M
-138.29M
-257.39M
EBT excluding unusual items
22.07M
4.55M
-162.23M
-268.98M
Income tax expense
6.00M
-511.32K
6.56M
-32.54M
Effective tax rate
7.54%
-0.54%
-4.74%
12.64%
Other operating expenses
-48.55M
65.09M
1.87M
11.04M
Net income
71.01M
80.57M
-141.78M
-222.16M
Net profit margin
5.07%
4.42%
-16.96%
-27.53%
Earnings per share
-
-
-
-
Interest and investment income
2.87M
64.38M
20.33M
-
Interest expense
-12.84M
-10.27M
-8.66M
-26.90M
Net interest expenses
-9.97M
54.10M
11.67M
-26.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
62.93M
8.25M
-131.35M
-202.67M
Gain or loss from assets sale
-757.00
-673.04K
-
-1.18M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps